EYEPOINT PHARMACEUTICALS INC (EYPT) Institutional Shareholders
EYEPOINT PHARMACEUTICALS INC (EYPT) is currently reported in institutional portfolios tracked by InsiderSet based on the latest available SEC Form 13F filings for the quarter ended June 30, 2026. The institutional investors covered on this page collectively reported approximately $1.24B in EYPT holdings during the latest filing period.
Suvretta Capital Management, Llc is currently the largest disclosed institutional shareholder of EYPT tracked by InsiderSet, reporting ownership valued at approximately $118.64M in its June 30, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $31.94M, representing an estimated loss of -73.08% since the filing period.
The top 10 institutional shareholders tracked on this page collectively account for approximately 58% of the total disclosed EYPT value among the investors covered in this analysis. Major shareholders include Suvretta Capital Management, Llc, Blackrock, Inc., Cormorant Asset Management, Lp, and several other long-term asset managers with concentrated positions in EYEPOINT PHARMACEUTICALS INC (EYPT).
This page ranks the largest institutional EYPT shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.
Institutional Holders
178
Total Reported Value
$1.24B
Largest Holder
Suvretta Capital Management, Llc
Largest Position
$118.64M
Insider Transactions (90d)
7
Latest Filing Quarter
Q2 2026
New Institutional Positions
69
Funds Exiting Positions
0
| Name | Investor/Manager | Portfolio % | Quantity | Reported Balance | Current Estimated Value | Gain/loss Since Filing | Estimated Portfolio Performance |
|---|---|---|---|---|---|---|---|
| Suvretta Capital Management, Llc | 2.49% | 8,296,375 | $118,638,163 | $31,941,044 | -$86,697,119 | -73.08% | |
| Blackrock, Inc. | 0.00% | 7,463,197 | $106,723,718 | $28,733,308 | -$77,990,410 | -73.08% | |
| Cormorant Asset Management, Lp | 5.13% | 7,000,000 | $100,100,000 | $26,950,000 | -$73,150,000 | -73.08% | |
| Federated Hermes, Inc. | 0.12% | 5,681,052 | $81,239,044 | $21,872,050 | -$59,366,994 | -73.08% | |
| Adage Capital Partners Gp, L.L.C. | 0.10% | 4,827,792 | $69,037,426 | $18,586,999 | -$50,450,427 | -73.08% | |
| Commodore Capital Lp | 3.92% | 4,600,000 | $65,780,000 | $17,710,000 | -$48,070,000 | -73.08% | |
| Vanguard Capital Management Llc | 0.00% | 3,630,252 | $51,912,604 | $13,976,470 | -$37,936,134 | -73.08% | |
| Janus Henderson Group Plc | 0.02% | 3,601,168 | $46,419,056 | $13,864,497 | -$32,554,559 | -70.13% | |
| Paradigm Biocapital Advisors Lp | 0.77% | 2,890,397 | $41,332,677 | $11,128,028 | -$30,204,649 | -73.08% | |
| State Street Corp | 0.00% | 2,357,545 | $33,712,894 | $9,076,548 | -$24,636,346 | -73.08% | |
| Geode Capital Management, Llc | 0.00% | 2,062,390 | $29,497,382 | $7,940,202 | -$21,557,181 | -73.08% | |
| Aberdeen Group Plc | 0.04% | 2,008,802 | $28,725,869 | $7,733,888 | -$20,991,981 | -73.08% | |
| Citadel Advisors Llc | 0.02% | 1,977,610 | $28,279,823 | $7,613,799 | -$20,666,025 | -73.08% | |
| Balyasny Asset Management L.P. | 0.05% | 1,812,358 | $25,916,719 | $6,977,578 | -$18,939,141 | -73.08% | |
| Parkman Healthcare Partners Llc | 1.89% | 1,288,163 | $18,420,731 | $4,959,428 | -$13,461,303 | -73.08% | |
| Eventide Asset Management, Llc | 0.24% | 1,245,583 | $17,811,837 | $4,795,495 | -$13,016,342 | -73.08% | |
| Two Sigma Investments, Lp | 0.01% | 1,181,143 | $16,890,345 | $4,547,401 | -$12,342,944 | -73.08% | |
| Essex Woodlands Management, Inc. | 6.10% | 1,084,857 | $15,513,455 | $4,176,699 | -$11,336,756 | -73.08% | |
| Orbimed Advisors Llc | 0.29% | 1,069,147 | $15,288,802 | $4,116,216 | -$11,172,586 | -73.08% | |
| 5Am Venture Management, Llc | 5.22% | 1,050,000 | $15,015,000 | $4,042,500 | -$10,972,500 | -73.08% | |
| Rosalind Advisors, Inc. | 5.31% | 988,230 | $14,131,689 | $3,804,686 | -$10,327,004 | -73.08% | |
| Vanguard Portfolio Management Llc | 0.00% | 971,014 | $13,885,500 | $3,738,404 | -$10,147,096 | -73.08% | |
| Ameriprise Financial Inc | 0.00% | 848,410 | $12,132,298 | $3,266,379 | -$8,865,920 | -73.08% | |
| Dimensional Fund Advisors Lp | 0.00% | 841,746 | $12,035,896 | $3,240,722 | -$8,795,174 | -73.07% | |
| Hsbc Holdings Plc | 0.01% | 833,455 | $11,918,407 | $3,208,802 | -$8,709,605 | -73.08% | |
| Candriam S.C.A. | 0.05% | 787,769 | $11,254,258 | $3,032,911 | -$8,221,347 | -73.05% | |
| Artia Global Partners Lp | 2.09% | 767,098 | $10,969,501 | $2,953,327 | -$8,016,174 | -73.08% | |
| Blue Owl Capital Holdings Lp | 1.66% | 762,594 | $10,905,094 | $2,935,987 | -$7,969,107 | -73.08% | |
| Northern Trust Corp | 0.00% | 720,917 | $10,309,113 | $2,775,530 | -$7,533,583 | -73.08% | |
| Patient Square Capital Lp | 1.59% | 720,000 | $10,296,000 | $2,772,000 | -$7,524,000 | -73.08% | |
| Charles Schwab Investment Management Inc | 0.00% | 647,613 | $9,260,866 | $2,493,310 | -$6,767,556 | -73.08% | |
| Sio Capital Management, Llc | 1.53% | 623,130 | $8,910,759 | $2,399,051 | -$6,511,709 | -73.08% | |
| Vanguard Fiduciary Trust Co | 0.00% | 559,216 | $7,996,789 | $2,152,982 | -$5,843,807 | -73.08% | |
| Alyeska Investment Group, L.P. | 0.02% | 509,403 | $7,284,463 | $1,961,202 | -$5,323,261 | -73.08% | |
| Millennium Management Llc | 0.00% | 500,093 | $7,151,330 | $1,925,358 | -$5,225,972 | -73.08% | |
| Goldman Sachs Group Inc | 0.00% | 465,087 | $6,650,744 | $1,790,585 | -$4,860,159 | -73.08% | |
| Simplify Asset Management Inc. | 0.08% | 400,044 | $5,720,629 | $1,540,169 | -$4,180,460 | -73.08% | |
| Ghisallo Capital Management Llc | 0.10% | 350,000 | $5,005,000 | $1,347,500 | -$3,657,500 | -73.08% | |
| Stempoint Capital Lp | 0.84% | 338,471 | $4,840,135 | $1,303,113 | -$3,537,022 | -73.08% | |
| Morgan Stanley | 0.00% | 336,730 | $4,815,240 | $1,296,411 | -$3,518,830 | -73.08% | |
| E Fund Management Co., Ltd. | 0.11% | 330,774 | $4,730,068 | $1,273,480 | -$3,456,588 | -73.08% | |
| Jump Financial, Llc | 0.04% | 320,757 | $4,586,825 | $1,234,914 | -$3,351,911 | -73.08% | |
| Bleichroeder Lp | 0.81% | 316,515 | $4,526,165 | $1,218,583 | -$3,307,582 | -73.08% | |
| Woodline Partners Lp | 0.01% | 300,463 | $4,296,621 | $1,156,783 | -$3,139,838 | -73.08% | |
| Eversept Partners, Lp | 0.23% | 297,735 | $4,257,610 | $1,146,280 | -$3,111,330 | -73.08% | |
| Rock Springs Capital Management Lp | 0.19% | 268,519 | $3,839,822 | $1,033,798 | -$2,806,024 | -73.08% | |
| Citigroup Inc | 0.00% | 266,910 | $3,816,813 | $1,027,604 | -$2,789,210 | -73.08% | |
| Bank Of New York Mellon Corp | 0.00% | 250,783 | $3,586,192 | $965,515 | -$2,620,677 | -73.08% | |
| Myda Advisors Llc | 0.87% | 250,000 | $3,575,000 | $962,500 | -$2,612,500 | -73.08% | |
| Ubs Group Ag | 0.00% | 241,363 | $3,451,491 | $929,248 | -$2,522,243 | -73.08% |
Frequently asked questions about EYPT
Who owns the most EYPT stock?
The largest holders of EYPT are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for EYEPOINT PHARMACEUTICALS INC (EYPT).
Is EYPT widely held by superinvestors?
Many widely followed stocks like EYPT appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly EYPT is represented among the institutional managers we track.
What do “Current Estimated Value”, “Gain/loss Since Filing”, and “Estimated Portfolio Performance” mean?
Current Estimated Value is reported share quantity from the latest 13F times our most recent split-adjusted U.S. session close. Gain/loss Since Filing is that estimate minus the reported 13F dollar value; Estimated Portfolio Performance is that difference as a percent of the reported value. Green means the estimate is above the filing value; red means below (not purchase cost). If many filers share the same implied filing price per share, the performance % may match across rows. These are not official fund marks or live quotes.